Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohnʼs disease: A cautionary tale?

Therapy for the inflammatory bowel diseases increasingly includes the use of immune-modifying and biologic therapies. Recently, in young patients with IBD, an association has been noted between the use of infliximab along with concomitant purine analogues and the development of hepatosplenic T-cell ... View More